Clinical and pathological features of breast cancer patients in the geriatric population

Ömer Acar

Makale detayları

Clinical and pathological features of breast cancer patients in the geriatric population

Yazarlar:

Ömer Acar

Yayıncı:

Cukurova University

Ana Başlıklar:

Cerrahi Onkoloji | Geriatri ve Gerontoloji

Dergi:

Cukurova Medical Journal Vol.49 Issue 4, pp.958-964

Belge Tipi:

Makale

Yayın Tarihi:

12/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001329053

pISSN:

2602-3032

Anahtar kelimeler:

Özet:

 Purpose: A significant portion of patients diagnosed with breast cancer are over the age of 65. Elderly patients are often excluded from prospective clinical trials due to comorbidities. Clinicians have different treatment management options for elderly patients. Under-treatment or over-treatment may negatively affect treatment outcomes and prognosis. There are few data to guide treatment decisions. We present the clinical and pathological features of elderly breast cancer patients followed in our cancer center. Materials and Methods: A retrospective review of files about surgically treated patients with breast cancer was conducted. The prognostic impact on overall survival and progression-free survival was assessed. Results: The study encompassed a total of 101 patients. The median age was 67 65-81 years. Approximately half of the patients were classified as TNM stage 2. The majority of them had undergone modified radical mastectomy. 15.8 received neoadjuvant chemotherapy. 84.2 had invasive ductal carcinoma histological subtype. progression-free survival was lower in patients receiving neoadjuvant chemotherapy with pathological N3 lymph nodes and in HER2-positive patients. The 5-year survival rate was 61.7 in patients with N3 pathological lymph nodes, 91 in those with N2 pathological lymph nodes, and 100 in patients with N1 or N0 pathological lymph nodes. Conclusion: The pathological stage was associated with survival. The presence of pathological N3 lymph nodes resulted in lower progression-free survival and lower overall survival. Regardless of age, patients with good performance, who are not frail, and who have no comorbidities should be encouraged to receive current therapy.

 Purpose: A significant portion of patients diagnosed with breast cancer are over the age of 65. Elderly patients are often excluded from prospective clinical trials due to comorbidities. Clinicians have different treatment management options for elderly patients. Under-treatment or over-treatment may negatively affect treatment outcomes and prognosis. There are few data to guide treatment decisions. We present the clinical and pathological features of elderly breast cancer patients followed in our cancer center. Materials and Methods: A retrospective review of files about surgically treated patients with breast cancer was conducted. The prognostic impact on overall survival and progression-free survival was assessed. Results: The study encompassed a total of 101 patients. The median age was 67 65-81 years. Approximately half of the patients were classified as TNM stage 2. The majority of them had undergone modified radical mastectomy. 15.8 received neoadjuvant chemotherapy. 84.2 had invasive ductal carcinoma histological subtype. progression-free survival was lower in patients receiving neoadjuvant chemotherapy with pathological N3 lymph nodes and in HER2-positive patients. The 5-year survival rate was 61.7 in patients with N3 pathological lymph nodes, 91 in those with N2 pathological lymph nodes, and 100 in patients with N1 or N0 pathological lymph nodes. Conclusion: The pathological stage was associated with survival. The presence of pathological N3 lymph nodes resulted in lower progression-free survival and lower overall survival. Regardless of age, patients with good performance, who are not frail, and who have no comorbidities should be encouraged to receive current therapy.

 Purpose: A significant portion of patients diagnosed with breast cancer are over the age of 65. Elderly patients are often excluded from prospective clinical trials due to comorbidities. Clinicians have different treatment management options for elderly patients. Under-treatment or over-treatment may negatively affect treatment outcomes and prognosis. There are few data to guide treatment decisions. We present the clinical and pathological features of elderly breast cancer patients followed in our cancer center. Materials and Methods: A retrospective review of files about surgically treated patients with breast cancer was conducted. The prognostic impact on overall survival and progression-free survival was assessed. Results: The study encompassed a total of 101 patients. The median age was 67 65-81 years. Approximately half of the patients were classified as TNM stage 2. The majority of them had undergone modified radical mastectomy. 15.8 received neoadjuvant chemotherapy. 84.2 had invasive ductal carcinoma histological subtype. progression-free survival was lower in patients receiving neoadjuvant chemotherapy with pathological N3 lymph nodes and in HER2-positive patients. The 5-year survival rate was 61.7 in patients with N3 pathological lymph nodes, 91 in those with N2 pathological lymph nodes, and 100 in patients with N1 or N0 pathological lymph nodes. Conclusion: The pathological stage was associated with survival. The presence of pathological N3 lymph nodes resulted in lower progression-free survival and lower overall survival. Regardless of age, patients with good performance, who are not frail, and who have no comorbidities should be encouraged to receive current therapy.

 Amaç: Meme kanseri teşhisi konulan hastaların önemli bir kısmı 65 yaşın üzerindedir. Yaşlı hastalar genellikle eşlik eden hastalıklar nedeniyle prospektif klinik çalışmalardan hariç tutulur. Klinisyenlerin yaşlı hastalar için farklı tedavi yönetimi seçenekleri vardır. Yetersiz tedavi veya aşırı tedavi tedavi sonuçlarını ve prognozu olumsuz etkileyebilir. Tedavi kararlarına rehberlik edecek çok az veri vardır. Kanser merkezimizde takip edilen yaşlı meme kanseri hastalarının klinik ve patolojik özelliklerini sunuyoruz. Gereç ve Yöntem: Cerrahi olarak tedavi edilen meme kanseri hastalarının dosyalarının retrospektif bir incelemesi yapıldı. Genel sağkalım ve progresyonsuz sağkalım üzerindeki prognostik etki değerlendirildi. Bulgular: Çalışma toplam 101 hastayı kapsıyordu. Ortanca yaş 67ydi 65-81. Hastaların yaklaşık yarısı TNM evre 2 olarak sınıflandırıldı. Çoğunluğu modifiye radikal mastektomi geçirmişti. 15.8i neoadjuvan kemoterapi aldı. 84.2sinde invaziv duktal karsinom histolojik alt tipi vardı. Patolojik N3 lenf nodları olan ve neoadjuvan kemoterapi alan hastalarda ve HER2 pozitif hastalarda progresyonsuz sağkalım daha düşüktü. N3 patolojik lenf nodları olan hastalarda 5 yıllık sağkalım oranı 61,7, N2 patolojik lenf nodları olan hastalarda 91 ve N1 veya N0 patolojik lenf nodları olan hastalarda 100 idi. Sonuç: Patolojik evre sağkalımla ilişkiliydi. Patolojik N3 lenf nodlarının varlığı daha düşük progresyonsuz sağkalım ve daha düşük genel sağkalımla sonuçlandı. Yaştan bağımsız olarak, iyi performans gösteren, güçsüz olmayan ve komorbiditesi olmayan hastalar güncel tedaviyi almaya teşvik edilmelidir.

Makale detayları

Clinical and pathological features of breast cancer patients in the geriatric population

Yazarlar:

Ömer Acar

Yayıncı:

Cukurova University

Ana Başlıklar:

Cerrahi Onkoloji | Geriatri ve Gerontoloji

Dergi:

Cukurova Medical Journal Vol.49 Issue 4, pp.958-964

Belge Tipi:

Makale

Yayın Tarihi:

12/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001329053

pISSN:

2602-3032

geriatric breast cancer

overall survival

fragilityGeriatrik meme kanseri

genel sağ kalım

kırılganlık

Sayı

Makale detayları

Clinical and pathological features of breast cancer patients in the geriatric population

Yazarlar: Ömer Acar

Yayıncı: Cukurova University

Ana Başlıklar: Cerrahi Onkoloji | Geriatri ve Gerontoloji

Dergi: Cukurova Medical Journal Vol.49 Issue 4, pp.958-964

Belge Tipi: Makale

Yayın Tarihi: 12/2024

Belge Dili: İngilizce

Document ID (Org No.): 2001329053

pISSN: 2602-3032

geriatric breast cancer

overall survival

fragilityGeriatrik meme kanseri

genel sağ kalım

kırılganlık

Sayı

Yazarlar:

Ömer Acar

Yayıncı:

Cukurova University

Ana Başlıklar:

Cerrahi Onkoloji | Geriatri ve Gerontoloji

Dergi:

Cukurova Medical Journal Vol.49 Issue 4, pp.958-964

Belge Tipi:

Makale

Yayın Tarihi:

12/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001329053

pISSN:

2602-3032